Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Franc Anderluh"'
Autor:
A. Secerov-Ermenc, Irena Oblak, M. Peternel, Mojca Tuta, Franc Anderluh, Erik Brecelj, A. Jeromen Peressutti, Nina Boc, Vaneja Velenik
Publikováno v:
Annals of Oncology. 31:S147
Autor:
Ana Jeromen, J. But-Hadzic, B. Krebs, Erik Brecelj, Vaneja Velenik, Irena Oblak, Janja Ocvirk, A. Secerov-Ermenc, Franc Anderluh, N. Boc
Publikováno v:
Annals of Oncology. 30:iv34
Autor:
Vaneja Velenik, Irena Oblak, Ana Jeromen, Franc Anderluh, J. But-Hadzic, A. Secerov-Ermenc, Erik Brecelj
Publikováno v:
Annals of Oncology. 29:v30
Publikováno v:
Annals of Oncology. 26:iv43
Publikováno v:
Annals of Oncology. 25:iv200
Aim: Preoperative capecitabine-based chemoradiotherapy (CRT) is widely used treatment for resectable locally advanced rectal cancer (LARC). In order to improve efficacy, we conducted a phase II study in which the epidermal growth factor receptor-targ
Autor:
Ana Jeromen, Franc Anderluh, Vaneja Velenik, Ivica Ratosa, Marija Skoblar Vidmar, Irena Oblak
Publikováno v:
Annals of Oncology. 23:iv60-iv61
Introduction Adenocarcinomas of gastroesophageal junction (GEJ) represent a heterogenic group of tumors with poor prognosis. The principal treatment of nonmetastatic GEJ is surgical resection with 5-year survival rate of approximately 20%. It is clea
Publikováno v:
Annals of Oncology. 24:iv42
Autor:
Mirko Omejc, Vaneja Velenik, Janja Ocvirk, Bracˇko Matej, Irena Oblak, Erik Brecelj, Franc Anderluh, Ibrahim Edhemovic, Mateja Kropivnik, Maja Mušicˇ
Publikováno v:
Annals of Oncology. 23:iv113
Introduction Neoadjuvant capecitabine based chemoradiotherapy and radical surgery are considered to be optimal treatment approach to locally-advanced rectal cancer. We assessed the efficacy and safety of adding targeting agent bevacizumab to this sta
Autor:
Irena, Oblak, Franc, Anderluh, Vaneja, Velenik, Jasna, But-Hadzic, Ajra, Secerov-Ermenc, Ana, Jeromen, Ivica, Ratosa
Publikováno v:
In Annals of Oncology June 2014 25 Supplement 2:ii29-ii29